Rhumbline Advisers CONDUIT PHARMACEUTICALS Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Number of Shares
20,037
Previous 23,899
16.16%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%